Invicta Medical is a clinical-stage medical technology company specializing in developing innovative therapies for sleep apnea. They are focused on revolutionizing the treatment of sleep apnea by offering smart, comfortable, and cost-effective solutions through their intelligent neurostimulation system. The company aims to address the shortcomings of existing therapies, which are expensive and intrusive, leading to low patient compliance rates. With a strong emphasis on research and development, Invicta Medical has raised significant funding and is supported by experienced investors and advisors from renowned universities and medical institutions.